[3-[4-(4-chloro-2-methylsulfanylphenyl)phenyl]azetidin-1-yl]-[6-(triazol-2-yl)-2-azaspiro[3.3]heptan-2-yl]methanone
C25H26ClN5OS — CID 166083921
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-[4-(4-chloro-2-methylsulfanylphenyl)phenyl]azetidin-1-yl]-[6-(triazol-2-yl)-2-azaspiro[3.3]heptan-2-yl]methanone
[3-[4-(4-chloro-2-methylsulfanylphenyl)phenyl]azetidin-1-yl]-[6-(triazol-2-yl)-2-azaspiro[3.3]heptan-2-yl]methanone (PubChem CID 166083921) has the molecular formula C25H26ClN5OS and a molecular weight of 480.04 g/mol. Its IUPAC name is [3-[4-(4-chloro-2-methylsulfanylphenyl)phenyl]azetidin-1-yl]-[6-(triazol-2-yl)-2-azaspiro[3.3]heptan-2-yl]methanone.
Molecular Properties
| Compound Name | [3-[4-(4-chloro-2-methylsulfanylphenyl)phenyl]azetidin-1-yl]-[6-(triazol-2-yl)-2-azaspiro[3.3]heptan-2-yl]methanone |
|---|---|
| PubChem CID | 166083921 |
| Molecular Formula | C25H26ClN5OS |
| Molecular Weight | 480.04 g/mol |
| Exact Mass | 479.15 |
| IUPAC Name | [3-[4-(4-chloro-2-methylsulfanylphenyl)phenyl]azetidin-1-yl]-[6-(triazol-2-yl)-2-azaspiro[3.3]heptan-2-yl]methanone |
| SMILES | CSc1cc(Cl)ccc1-c1ccc(C2CN(C(=O)N3CC4(CC(n5nccn5)C4)C3)C2)cc1 |
| InChI | InChI=1S/C25H26ClN5OS/c1-33-23-10-20(26)6-7-22(23)18-4-2-17(3-5-18)19-13-29(14-19)24(32)30-15-25(16-30)11-21(12-25)31-27-8-9-28-31/h2-10,19,21H,11-16H2,1H3 |
| InChIKey | OVZWVWXFAWEUPO-UHFFFAOYSA-N |
| XLogP | 5.18 |
| TPSA | 54.26 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.04 |
| LogP ≤ 5 | 5.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166083921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.